IIB 

116TH CONGRESS 

2D SESSION H. R. 4812 

IN THE SENATE OF THE UNITED STATES 

NOVEMBER 18, 2020 

Received; read twice and referred to the Committee on the Judiciary 

AN ACT 

To amend the Controlled Substances Act to provide for the 

modification, transfer, and termination of a registration 

to manufacture, distribute, or dispense controlled substances or list I chemicals, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


pamtmann on DSKBC07HB2PROD with BILLS
2 

HR 4812 RFS

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Ensuring Compliance 

3 Against Drug Diversion Act of 2020’’. 

4 SEC. 2. MODIFICATION, TRANSFER, AND TERMINATION OF 

5 REGISTRATION TO MANUFACTURE, DIS6 TRIBUTE, OR DISPENSE CONTROLLED SUB7 STANCES. 

8 Subsection (a) of section 302 of the Controlled Sub9 stances Act (21 U.S.C. 822) is amended by adding at the 

10 end the following new paragraph: 

11 ‘‘(3)(A) Except as provided in subparagraph (C), the 

12 registration of any registrant under this title to manufac13 ture, distribute, or dispense controlled substances or list 

14 I chemicals terminates if and when such registrant— 

15 ‘‘(i) dies; 

16 ‘‘(ii) ceases legal existence; 

17 ‘‘(iii) discontinues business or professional prac18 tice; or 

19 ‘‘(iv) surrenders such registration. 

20 ‘‘(B) In the case of such a registrant who ceases legal 

21 existence or discontinues business or professional practice, 

22 such registrant shall promptly notify the Attorney General 

23 in writing of such fact. 

24 ‘‘(C) No registration under this title to manufacture, 

25 distribute, or dispense controlled substances or list I 

26 chemicals, and no authority conferred thereby, may be asVerDate Sep 11 2014 18:19 Nov 19, 2020 Jkt 019200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H4812.RFS H4812

pamtmann on DSKBC07HB2PROD with BILLS
3 

HR 4812 RFS

1 signed or otherwise transferred except upon such condi2 tions as the Attorney General may specify and then only 

3 pursuant to written consent. A registrant to whom a reg4 istration is assigned or transferred pursuant to the pre5 ceding sentence may not manufacture, distribute, or dis6 pense controlled substances or list I chemicals pursuant 

7 to such registration until the Attorney General receives 

8 such written consent. 

9 ‘‘(D) In the case of a registrant under this title to 

10 manufacture, distribute, or dispense controlled substances 

11 or list I chemicals desiring to discontinue business or pro12 fessional practice altogether or with respect to controlled 

13 substances and list I chemicals (without assigning or 

14 transferring such business or professional practice to an15 other entity), such registrant shall return to the Attorney 

16 General for cancellation— 

17 ‘‘(i) the registrant’s certificate of registration; 

18 ‘‘(ii) any unexecuted order forms in the reg19 istrant’s possession; and 

20 ‘‘(iii) any other documentation that the Attor21 ney General may require.’’. 

22 SEC. 3. DETERMINATION OF BUDGETARY EFFECTS. 

23 The budgetary effects of this Act, for the purpose of 

24 complying with the Statutory Pay-As-You-Go Act of 2010, 

25 shall be determined by reference to the latest statement 


pamtmann on DSKBC07HB2PROD with BILLS
4 

HR 4812 RFS

1 titled ‘‘Budgetary Effects of PAYGO Legislation’’ for this 

2 Act, submitted for printing in the Congressional Record 

3 by the Chairman of the House Budget Committee, pro4 vided that such statement has been submitted prior to the 

5 vote on passage. 

Passed the House of Representatives November 17, 

2020. 

Attest: CHERYL L. JOHNSON, 

Clerk. 


pamtmann on DSKBC07HB2PROD with BILLS